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A 2S year-old Hawaiian Chinese man o as admitted for abdominat.
do.eomtort. The patient had a six.-month hstor of ree.urrent venuus
thromboembolie disease ineludinrz multi pie bilateral loss er extrem
it\ 1)\ Is and puhnonarv cmhoh His abdoinnal pain had increased
n intetisitv os erthe sseek priortoadnision and ss asassoeiatedwith
an increase in abdominal irth and eonripation. He also noticed
swelling of his right calf similar to his past DV[s, and o orsenmg
shortness of breath,
The patient’s past tedieal history ss as significant Or recurrent
looser cxtreinit\ D’v 0 and pulrnonar umboli Os er the i s months
odor to admission, despite heitie adequately anticoacrilated with
ss art arm Fl is past ss ork up I) r he redi tarr causes ot thron i boph il
had been negative, and he was eurrentl being treated with suheu
taneous low molecular weight heparin. enoxaparin 1 mg/kg twice
dailr The patient had no family hislorr of thrombopbilia He
smoked ci carettes one pack per dar. i oed nlarli cina. hut did not
drink ileohol nor tra\ el outside of the i tired States. He o orked as
a Orklift operator and had no sis’nifieant occupational exposures.
Physical examination revealed an obese man with mild dyspnea.
atemperature of 99.2 degrees, blood pressure 122/78 mm Hg. pulse
I 3 heats/nun, and respit’ator\ ate 20 breaths/mm \vitll an oxygen
saturation of 99s on room air hr pulse oximetrv, His C\aiii
demonstrated seleral dents and iaundieed skin. Caidim ascular
exani was sigititieant t)r taeh eLirdia and lung fields were clear. His
abdomen was slightly distended with hepatosplenomegalv and
aseites. Bilateral calf tenderness and so elling to 48 em eireumtèr
enee were also pre’m Lahoratorr studies o crc senilicant tor
hilirubin 2.SincjdL itt. I -1.0 me/di. AST I 70 [/1 0-40 k/lt. ALl
52 ki 0-45 k /i;e albumin 1.1 u/dL 3.5- 5.0 iodLi. and alkaline
phosphatase 25 U/I (25-125 U/I), His calcium was I 4,Sntg/dL (8.6-
I (1.7 mg/dO and his PTH wasS pg/mi.. 10-65 pg/mU). Perfusion-
ventilation nuclear medicine sean demonstrated let) temorel and let)
iltac em thromhots estendiuc t the intdrior rena ear a. and hich
probability of bilateral pulmonary etnboli.
Hm hvperwmleemia 55.15 treated with lmvdtation and’ turoenndc
well as pamidronate. On admission. he. si as also anrteoagu.lated wi.tii
continu.ous infu.sion of u.nfraetionat.ed hcparin.
Eu it her so rk up re’ ea led ru omal PS 1. A EP mud hUG. hut an
ales iied(’E.-\ SSnc/tnl.. norns.t) 1-S ne/mLau5tC\ 0-9
nornllil 46 Foul. . Ci scan 0 oplaved Grey. hr ndOnc
areas t t.G. rich l.obe f the liver and e r idenee of right. lieparie ye
thrombosis (Figure 1), A subsequeni biopsy of the. liver was
con.s iste.nt with e.hohneioeareinoma (Figure. 2). The patient chose
to undergo5hemothcrctv. and as treated s’. itli one c’ursc of 5..
flurroatacil. He later developed hepaOremmal failure rUth hvoten
Discussion
This patient presented with hr pcreaiccmia luld threumbophilia. eons
plicat ions often seen in malignancy. The following dtseussiou
addres se•s th.e •vrri.iotis e.ti.ologies of h.ype.realeerni.a. m.eeh.anisrns
spect tic to hr perealecniia in mnahgnsmncr. and treatment of the
c.ndimiou ‘[hisuihouhilia and t Itereditlirs and ,tcquired emuses are
also Jesem (ted. The article focuses on the cmaidemmolnsv [ ‘elf) iii
cancer pat.ients. and the efficac v and praeticalit of screening try
tumors i.n patients pre.senting svith thronibophilia.
Hypercalcemia
Hspcrealcemnism “il’. when emlc.iuni is 1tborhcd toni the intestine
and cot’beJ r,,0. r{’miy fater thlal it csereted in the urine- and
depos. red in hone, 0 the diagnostic. workup, it is helpful to thin.k of
diseases that can alter the.se. proees ens, (Table. I)
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Figure 1.—CT scan of abdomen revealing multiple dilated ducts and
a large hypodense region in the liver.
Figure 2.— Biopsy of tumor demonstrating atypical ducts consistent with an
adenocarcinoma. anisokaryosis and an increased nuclear to cytoplasmic
ratio.
H perparal h\ roid m is the most c on mon cause it lperea1ce
mia in the amhulator\ setting. accounting tar over fH)fa of cases,
Among hospitalized patients however, 60% of hypercalcemic states
are due to cancer. H percalcemia occurs in I 0 to 20% of cancer
patieins. and i’ most prevalent in those vnh breast cancer, lung
cancer and niuluple niveloma, Three mechamsnts have been dis—
cLissed: osteol\ tic metastases with local cytokine merhators. secre
tion of PTH—related protein (PTI—{rP e and tumor production of
alcitriol I 2 ( oH ) \ it 1mm I) ) I hc I ihoi ator L \ ilu ition of
h\ percalccniia n this group should include a PTH le\ el because
there is also a higher incidence of primar\ hperparathroidism
among cancer patients than in the general population.
Breast and tion—small cell lung cancers and other solid tumors that
metastasize to the hone produce tumor necmsis factor. interleukin—
I and thercrukines that tiniulate osteoelastic aeti\ dv. This local
induction ol honeresorption increases sernmcaieium leseis. PTHrP
mediated hvpercalceniia. also called humoral hyperealceinia of
malignancy, is the most common cause of hypercalcemia in
nonmetastatic tumors and non—Hodgk ins lyniphomas. PTHrP acts
in a manner similar to PT H increasing hone resorption and calcium
reah.orption in the kidneys. The diagnosis mae be made by
measuring serum PTHrP levels. hut eurrentl no treatment is a ail
ahle to inhibit its release, Tumor cell production of calcitriol is
responsihle for hypercalcemia in almost all cases of Hodgkin’s
mphonia and about a third al the cases of non—Hodgkin’ K m—
phoma High ealcitril titer increa’e intestinal absorption ot
caici unt and hne resorption.
The Iivpercalcemic patient often presents s oh nonspecific com
plaints of fatigue., anorexia, nausea. vonuting, abdominal pain.
constlpatlon. pldipsia nd uria. Neurological nanifcsiations
nate ange from weakness and lctharc\ to altered mental status and
ephrogeuic diabetes insipidus and renal failure secordar\
to volume contraction and direct parenchumal damage also may
oc.c.ur, The. se.verit. of the signs and symptoms depend on hoth the
degree and rate of incease in calcium levels.
First-line team-cit hvoeelceiiii in cancerpattents is appro
treatment of the i1aiieiianc- nfortunateh - niost patenO.
presentine s tb high serum calcium are in advanced stages of
disease, and must he treated by other modalities, Normal saline
infusion is often helpful because patients will present with hvpov—
olemia secondary to omiting and polvuria. Loop diuretics like
furosemide have a Ii in ted effect on increasing calcium escretiun.
Bisphosphonaies are effectis e in inhibiting osteoclastic activit\ and
thus resorption from the hone. Pamidronate or zoledronate are the
preferred hisphosphonates available in the US and are dosed every
IWO to tour weeks, Gallium nitrate also inhibits hone resorption. hut
its use is limited h its nephrotoxieit . It should not he given with
ther itentj a I neph roioxie acents. (.‘alei toni ii treats hvpercaleenii a
h both inhibiting hone resorption atid through increasing calcium
excretion via the kidne. Calcitonin therapy is usually limited to two
to three days due to tachyphvlaxis. Plicanivein is anotherosteoclast
inhibitor. hut ith se crc ad erse effaets inelndinia nephrotosicitv.
hepatoto\icit\ . thronthocrtopenia. and coaguIopath
. Severe mani
festations of h percaleemia. such as coma. niay require hemodial—
sis,
Thrombophilia
Thronibophilia leading to enous thromhoembolism I \ TE i is re
sponsible for 250,000 hospitalizations per ear. It is a major risk
factor tor pulmonary embolism, which in turn accounts for 50.000
deaths a year. The most comnion hereditar etiologies of throinho—
philia are taetor V Leiden. pi’othromhnt (12021 0A. anuthrombin Ill
ATI lIe proteni C’. and protein S mutations. Together they are
responsible for SOto Soft- of all VTE cases.— Acquired thombophilic
defects include trauma, pregnancy. surgery. prolonged immobiliza
tion. nephrotic su-ndrome, antiphospholipid svndronie. and nialig—
nanc . Hperhomocvsteineinia is another common etioIog
. and
can he either hereditar\ or acquired.
Factor V Leiden
In the coagulation pathway. factor Va and tactor Xa convert pro—
thrombin to thromhin. [)uri ng fibrinolvsis. activated protei ii C
cleaves Iactor Va. rendering it maclive. The factor V I..eiden
mutation ins ols es a replacement of glutamine for ai’ginine at posi
tion 506 during the synthesis of factor V. This suhstituuon slows the
rate of inactivation of factor Va, leading to increased levels of the
clotting factor. i’ss o pathophvsiologic mechanisms this e been
proposed to e.splamn the rhrombophi lie risk in these patients: I irsi. hs
c mvert i ng more prot Ii ri onhi n to thr )nhin . and sec nd. through
sIo in, fthrinols sts hs dvrc ising thL. actis tt of protein C
Factor V Leiden is the most common hereditary prothrombotic
disorder. The ethnic ariation among factor \ Leiden patients is
significant for a high prevalence anionc Caucasians 5.27K . coin-
pared to Asian 0.45’-’ and African i I .21 populations. In
comrast to its high pres alence, the factor V Leiden carries a low risk
for VTE relative to other hereditary mutations. Heterozr gotes
iefatise rik 5- lOihavea loss er risk than hoino, cotes relatis e risk
t.); and compound heterozygotes for other thronihophilic muta
tiOiis. -
Prothrombin G2021 OA
Pmothnonhiu (121)2 ltlA is a substitution of alanine far crianinc in the
untranslated S icgion ol the proihronhin niRNA. I-ieteioz\ gotes
mm i tIn in it itmon i hc,ji hi i a ha U i,hs i pm hm ni
Table 1 .— Differential Diagnosis of Hypercalcemia
Increased intestinal absorption
milkoikat syndrome -
rn-nm gra;n eomatous dseases
malignant lymahoma
acromegamy
Decreased renal excretion
Increased bone resorption! Decreased bone deposition
hyperparathyroidisrn
hyneortaminosa A
lithtum (via PTH-related protein(
pheochromocytoma (via PTH-related orotein(
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bin levels. This is belies ed to be the niechunism for the proeoagnlant
aeti vitv.
The G202 1 hA ii utation. with a prevalence of 2ff is the second
most common hereditarr cause ut thrombophilia. Snuilar to the
factor V leiden detect, this trait is more common in Caucasian
populations. The G202 t)-\ heteroz 2oie has e a lower risk of \ TE
(RE 25) compared to AT 111. protein C or S carriers or compound
hcterozygotes.4
Antithrombin III, Protein C, Protein S
AT III, protein C and protein S areentmes required for l’ibrmnol\ sis.
[)cliciencics in their amount or function can lead to a thrombophilic
state. Homozygons or compound heterozytous protein C and S
patients des clog usuall\ fatal condinon called pum’ptira tulminans.
Fhns .adult patients are hcterotseoims or conipound hcterozyeoies
s.s tilt the actor V [eider detect.
AT Ill is an irresersible inhibitor of thromhni and other clotting
Cictors. Protein C interacts with protein S to inactivate factors Va
and VITa and to induce fibrmnols Sis. Mutations in the ceiles of these
enzymes lead to either reduced s nthesis at the proteni or deereaed
en/\ matic function. AT III. protein C. and protein S defects account
tor 5 l5 of VTE events. - A study comparing hcreditar\ defects of
coagulation revealed the folloss ing relative risks of thrombosis
conipared to individuals with no defects: anuihromhin III X. I
Protein C ‘E.3. Protein S 5.5. and factor \- Leiden 2.2: In establishing
a laboratorx diagnosis. it i iniportant to rementher that AT III.
protein C and S may he falsely loss in an acute episode of thrombo
sis,’ Also. heparin may decrease levels of AT III, and ssarl’arin may
reduce les els of prolem C’ and S. Screening forthcse defects should
be delayed until Isso ss-eeks after ;mticoaeulation medications liase
been stopped.
Antiphospholipid Syndrome
Anliphospholipid antibodies (APi As) are autoantihodmes including
the lupus anticoagulant and anfieardmolipnt anlibods. ‘I hese anti
bodies arc more pi’evaleni in the elderlr. people ss ith autoinlmnne
diseases or HIV, and patients on niedications such as procainamide.
qumdine. and chlorpromazine. Similar to hypcrhomocysteinemia,
API.As are responsible for both arterial and venous thrombi, Pro
posed niechanisins for the thrombotic acims its of APL-\s include
inducing ncreased adherence of platelets and monoer tes to the
cndothclial wall, alteration of the thronmboxamiciprostacselin bak
ance, and functional impairment of antithrombin Ill. protein C.
profein S. and other coagulation inhibitors,
The pme alenec afAP[ --\ raimee’ from to is to 5 amnamic heulths
blood donors, while for patients ss itli sxstenmic lupns err theimmou5
it can be as high as 60’ . Fhc logos antieoayulamim has been
associ.ate.d with a •hiher t.hrornboti.c ri.sk th.an the ant.ie.ard.iol.ipin
antibody.
Hyperhomocysteinemia
l-lomnocs mcmne an anlimmo acid forimied fo mime mctahsmnsii of
methlomne. Elevatiom. in h.mocvsteinc.. level, can he c.aused by
genetic detects. nutritional deficiencies itamin P6. vitamin B I 2.
and (elate. meJ1catmsn eholest’. ‘ammue. arhamatepe.
am. liac in-. and thcophr incu and is-er or lenal taiinm’e.
While [crc are numerous caseeomitrs”l ansi e’esssce eat stud
ies reporting a st m’omlg association berss ccii li perhom cr ‘let ne iii ma
and atherosclerotic events, there is sortie contros ersy’ sui’roundirig
the relationship. Possible prothrombotic mechanisms of homocvs
fenc include endothelial d\ sfumiction due to free radical formation
durimig the reduction of’ lionlocysleine. direct inhibition of endothe
hal cell gross th. dim’ect platelet proaggrcgatorr elf’ecis. arid promo
tion of leukocs te recruitment. It is still unclear whether
hr perhomocysteinemia is a cause of thrombophilia or a marker of
thrombosis, and larger prospectis c sftmdmes are needed to elucidate
this issue.’
Studies directed specificalls am VI E have toumid an odds ratio
2.5 to 2,O5anioue patients with homocx’steine levels gm-cater than
to o standard deviations above the mean value of the control group.’
Malignancy
The assoeiatmon of maliemiancy amid \-‘‘l’E is xs-’ell documented iii mite
literature. In our patient without thrombotie risk factors ss ho
presented with hr percalcemia and recurrent V’I’E, there was a high
suspicion of cancer. Cancer increases the risk for thi’omhotic cx emits
through activation ofeloitimig hr inniorcells. endotheimal imijurs. aitu
stasis. [poim pooliimg the m’csm,iltsol multiple retrospective studic. ilme
odds ratio for miesvly diagimosed malignancy in patients ss Oh VTE as
compared to those without VTE is 2,09 95ff Cl I .72-2,54), The
dds rat i for newly diagnosed mal iunancv in idiopathic V’l’E
conipared with secondarr VTE is-- even higher. OR 4.51 m95’. C I
3.15 to n.72 ; The greatest risk for cancer is ceii ni those ss ith
m’ccurrenm V”FE suel’m as this patient.
Large retrospective studies have determined that cancers of’ the
pancreas. liver, os ary, and brain are most strongly associated ss ith
\ T’E. l’hese tumors lack ohviotms earls pi’esemlting signs, and are
oltei’idiscos emedat laterstages. Thispatient witl’mcholaneiocarcmnoima
pm’esented at an ads anced stage xx mth V’T’E being one of his pm’esenting
signs.
.-\lthough am’elatmonship between VTE and cancerhas been clearly
dcmonsti’ated, decidimig o hethertoscreen lorcaneerin a patient is ho
prems omih i)\ ‘1 memnamims a coiiti’os-crsial i’sue. Studies shoss that
ili( st patieimts preseritinu ss ith D\ ‘T who are cx entual Is diagnosed
with cancer, had occult tumors at the tnmme of presentation.’ Thus,
thorough screening could potentially lead to eai’lier detect ion and
outcomes tI-mat are nmoi’e fax orable.
.-\n optmmnai cancer sereenins’ protocol in thm’onibophihia l’)temt’
should include ihmee pm’mneiples. Eirt, the exanminatmon shmommld avoid
causing further harms. discomfort or psychological stress. Invasive
tests should be postponed in the acute setting while patients are
amtieoaenlated tea’. aid bleedmnc complications. Second. sereenne
tests should yield ‘esnlts that could otemitialls chance the natural
history of’ the disease Lnfo-tunateis, for some of the canine’
c’ancers assoc.iate.d with VTE including tumors of the pan-c.re.as and’.
liver, earls’ detection does not necessarily’ change prognosis In
afdiiion. is cue lace cohort siuds xx Oh over 6.i,m(16, patients is
\ IL. -h)” patiemtsxvli we-re also ixi,mid tollus e a mali-manes
distant netastase’ and 15’- had regional spmead “ ‘ihezetf’e. a
majority ot,’t,he stnmdy patient.s presented s’ Oh advance.d disea.se, and
d:agnosis at’. time of VTE’ event w-as um’mhike.iy is’s alter prognosIs.
Ibid. time eeeo,’ p’oocol should be eost—etteeti\ e Beeue
mualenasev se ehati’.eis ac eau’e of thmonmhophihsa. it las not bc
is ,iIs mn iii sinus inn sC lilI_ I
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patient ho presents with primal’s \ E. Thus.
there are many i tacles to desigiiing an ideal
cancer screen iii g progrinL and at this t I me.
there is insulitcient es idence to support sereen
ing all patients diagnosed with idiopathic VTEs,
Further research ins olving prospective stud
ies ma\ help to reslil\ e this contros ersv,
Conclusion
In conclusion. nialigiiancz is part itt the cjier
ential liagnosi’ ut hoth h\ pcrcalcemia and
thronihophdia. Cancer is the mist comnion
etiology of hvpercalcemia among inpatients.
It is important to recognize the nonspecific
presenting complaints ot a hyperealcemic pa
tieni. and to he familiar ss ith the arious treat -
ments. ‘Thromhophilia is also a complication
ot nialignancy. and may he the presentine
sign. [Iii\\ ever, ereenin all ‘v [F patients tol
cancer remains controversial, Patients pre
senting with idiopathic VTE, recurrent VTE.
or other signs of malignancy (such as hyper
calcemia are at higher risk for having an
occult neoplasm. Further evaluation man he
warranted in these patents.
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Until there’s a cure, there’s the American Diabetes Association.
Until there’s a cure, there’s the American Diabetes Association.
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